共 5 条
First Successful Aortic Valve Implantation with the CoreValve ReValving™ System via Right Subclavian Artery Access: A Case Report
被引:91
作者:
Ruge, Hendrik
[1
]
Lange, Ruediger
[1
]
Bleiziffer, Sabine
[1
]
Hutter, Andrea
[1
]
Mazzitelli, Domenico
[1
]
Will, Albrecht
[2
]
Schreiber, Christian
[1
]
Laborde, Jean-Claude
[3
]
Bauernschmitt, Robert
[1
]
机构:
[1] Tech Univ Munich, German Heart Ctr Munich, Cardiovasc Surg Clin, D-80636 Munich, Germany
[2] Tech Univ Munich, German Heart Ctr Munich, Dept Radiol & Nucl Med, D-80636 Munich, Germany
[3] Clin Pasteur, Dept Cardiol, Toulouse, France
关键词:
D O I:
10.1532/HSF98.20081021
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
We successfully implanted a bioprosthetic aortic valve via the right subclavian artery within the framework of the CoreValve transapical aortic valve replacement (TAVR) ReValving (TM) (CoreValve, Irvine, CA, USA) clinical trial on November 20, 2007, at the Clinic for Cardiovascular Surgery at the German Heart Center Munich, Technical University Munich. The self-expanding aortic valve prosthesis is primarily designed for retrograde delivery across the aortic valve. The described approach via the right subclavian artery was performed because of severe peripheral vascular disease of the femoral and iliac arteries, as well as the left subclavian artery, and because a transapical delivery system was not available at the time of surgery.
引用
收藏
页码:E323 / E324
页数:2
相关论文